Rockwell Medical Stock Performance
| RMTI Stock | USD 2.31 0.06 2.67% |
The company holds a Beta of 1.64, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Rockwell Medical will likely underperform. At this point, Rockwell Medical has a negative expected return of -0.2%. Please make sure to check Rockwell Medical's treynor ratio, as well as the relationship between the kurtosis and day typical price , to decide if Rockwell Medical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Rockwell Medical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders. ...more
Actual Historical Performance (%)
One Day Return 4.66 | Five Day Return (6.18) | Year To Date Return 26.61 | Ten Year Return (97.64) | All Time Return (95.82) |
Last Split Factor 1:11 | Last Split Date 2022-05-13 |
1 | Disposition of 2163 shares by Mark Strobeck of Rockwell Medical at 3.6852 subject to Rule 16b-3 | 10/01/2024 |
2 | Garrison Asset Management LLC Sells 132 Shares of Rockwell Automation, Inc. | 11/04/2024 |
3 | Hedge Fund and Insider Trading News D.E. Shaw, David Einhorn, Israel Englander, Scott Bessent, Casdin Capital, Two Sigma Advisors, Brigade Capital, Rockwell Aut... | 11/13/2024 |
4 | This Turning Point Brands Analyst Begins Coverage On A Bullish Note Here Are Top 5 Initiations For Thursday | 11/14/2024 |
5 | CIBC Asset Management Inc Increases Holdings in Rockwell Automation, Inc. | 11/18/2024 |
6 | SouthState Corp Has 12.53 Million Position in Rockwell Automation, Inc. | 11/19/2024 |
7 | Rockwell Automation VP John Miller sells 132,659 in stock | 11/20/2024 |
8 | Microsoft Corporation and Rockwell Team Up to Revolutionize Manufacturing with AI and Cloud Solutions | 11/22/2024 |
| Begin Period Cash Flow | 10.1 M |
Rockwell |
Rockwell Medical Relative Risk vs. Return Landscape
If you would invest 307.00 in Rockwell Medical on August 27, 2024 and sell it today you would lose (82.00) from holding Rockwell Medical or give up 26.71% of portfolio value over 90 days. Rockwell Medical is currently does not generate positive expected returns and assumes 7.0303% risk (volatility on return distribution) over the 90 days horizon. In different words, 62% of stocks are less volatile than Rockwell, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Rockwell Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Rockwell Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Rockwell Medical, and traders can use it to determine the average amount a Rockwell Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0285
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | RMTI |
Estimated Market Risk
| 7.03 actual daily | 62 62% of assets are less volatile |
Expected Return
| -0.2 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Rockwell Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Rockwell Medical by adding Rockwell Medical to a well-diversified portfolio.
Rockwell Medical Fundamentals Growth
Rockwell Stock prices reflect investors' perceptions of the future prospects and financial health of Rockwell Medical, and Rockwell Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Rockwell Stock performance.
| Return On Equity | -0.29 | ||||
| Return On Asset | -0.0425 | ||||
| Profit Margin | (0.05) % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 68.62 M | ||||
| Shares Outstanding | 32.32 M | ||||
| Price To Earning | (14.72) X | ||||
| Price To Book | 2.50 X | ||||
| Price To Sales | 0.77 X | ||||
| Revenue | 83.61 M | ||||
| Gross Profit | 4.08 M | ||||
| EBITDA | (4.69 M) | ||||
| Net Income | (8.44 M) | ||||
| Cash And Equivalents | 27.56 M | ||||
| Cash Per Share | 2.37 X | ||||
| Total Debt | 13.44 M | ||||
| Debt To Equity | 1.38 % | ||||
| Current Ratio | 2.19 X | ||||
| Book Value Per Share | 0.73 X | ||||
| Cash Flow From Operations | (9.41 M) | ||||
| Earnings Per Share | (0.04) X | ||||
| Market Capitalization | 72.72 M | ||||
| Total Asset | 52.17 M | ||||
| Retained Earnings | (397.2 M) | ||||
| Working Capital | 12.13 M | ||||
| Current Asset | 84.63 M | ||||
| Current Liabilities | 8.09 M | ||||
About Rockwell Medical Performance
By evaluating Rockwell Medical's fundamental ratios, stakeholders can gain valuable insights into Rockwell Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Rockwell Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Rockwell Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 28.61 | 37.81 | |
| Return On Tangible Assets | (0.21) | (0.22) | |
| Return On Capital Employed | (0.19) | (0.20) | |
| Return On Assets | (0.16) | (0.17) | |
| Return On Equity | (0.40) | (0.42) |
Things to note about Rockwell Medical performance evaluation
Checking the ongoing alerts about Rockwell Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Rockwell Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Rockwell Medical generated a negative expected return over the last 90 days | |
| Rockwell Medical has high historical volatility and very poor performance | |
| Rockwell Medical has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 83.61 M. Net Loss for the year was (8.44 M) with profit before overhead, payroll, taxes, and interest of 4.08 M. | |
| Rockwell Medical currently holds about 27.56 M in cash with (9.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.37, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Rockwell Medical has a frail financial position based on the latest SEC disclosures | |
| Roughly 12.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from finance.yahoo.com: Microsoft Corporation and Rockwell Team Up to Revolutionize Manufacturing with AI and Cloud Solutions |
- Analyzing Rockwell Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Rockwell Medical's stock is overvalued or undervalued compared to its peers.
- Examining Rockwell Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Rockwell Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Rockwell Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Rockwell Medical's stock. These opinions can provide insight into Rockwell Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Rockwell Stock analysis
When running Rockwell Medical's price analysis, check to measure Rockwell Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rockwell Medical is operating at the current time. Most of Rockwell Medical's value examination focuses on studying past and present price action to predict the probability of Rockwell Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rockwell Medical's price. Additionally, you may evaluate how the addition of Rockwell Medical to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| CEOs Directory Screen CEOs from public companies around the world |